Insider · CIK 0001302450
Gunderson Robert V JR
Reports to the SEC for 4 companies · SAN FRANCISCO, CA
Transactions
39
Companies
4
Filings
10
CIK
0001302450
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-20 | ANDGAndersen Group Inc.P Purchase | +$84.8K |
| 2025-12-18 | ANDGAndersen Group Inc.P Purchase | +$202K |
| 2021-04-27 | TBPHTheravance Biopharma, Inc.A Award | — |
| 2021-04-27 | TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award | — |
| 2020-04-28 | TBPHTheravance Biopharma, Inc.A Award | — |
| 2020-04-28 | TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award | — |
| 2019-04-30 | TBPHTheravance Biopharma, Inc.A Award | — |
| 2019-04-30 | TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award | — |
| 2018-05-01 | TBPHTheravance Biopharma, Inc.A Award | — |
| 2018-05-01 | TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award | — |
| 2017-05-17 | TBPHTheravance Biopharma, Inc.A Award | — |
| 2016-10-25 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)D Disposition to Issuer | −$92.9K |
| 2016-10-25 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)D Disposition to Issuer | −$143K |
| 2016-10-25 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)D Disposition to Issuer | −$221K |
| 2016-10-25 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)D Disposition to Issuer | −$85.7K |
| 2016-10-25 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)D Disposition to Issuer | −$114K |
| 2016-10-24 | Vitae Pharmaceuticals, IncU Disposition from Tender | −$231K |
| 2016-10-24 | Vitae Pharmaceuticals, IncU Disposition from Tender | −$332K |
| 2016-05-26 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)A Award | — |
| 2016-05-03 | TBPHTheravance Biopharma, Inc.A Award | — |
| 2015-05-28 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)A Award | — |
| 2015-04-22 | TBPHTheravance Biopharma, Inc.A Award | — |
| 2014-09-29 | Vitae Pharmaceuticals, IncC Conversion | — |
| 2014-09-29 | Vitae Pharmaceuticals, IncC Conversion | — |
| 2014-09-29 | Vitae Pharmaceuticals, IncSeries A-2 Preferred StockC Conversion | — |
| 2014-09-29 | Vitae Pharmaceuticals, IncSeries B Preferred StockC Conversion | — |
| 2014-09-24 | Vitae Pharmaceuticals, IncStock Option (Right to Buy)A Award | — |
| 2013-04-24 | INVAInnoviva, Inc.A Award | — |
| 2013-04-24 | INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award | — |
| 2012-05-15 | INVAInnoviva, Inc.A Award | — |
| 2012-05-15 | INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award | — |
| 2011-04-27 | INVAInnoviva, Inc.A Award | — |
| 2011-04-27 | INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award | — |
| 2010-12-22 | INVAInnoviva, Inc.J Other | — |
| 2010-04-27 | INVAInnoviva, Inc.A Award | — |
| 2010-04-27 | INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award | — |
| 2009-04-24 | INVAInnoviva, Inc.A Award | — |
| 2009-04-24 | INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award | — |
| 2005-06-30 | INVAInnoviva, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Gunderson Robert V JR0001193125-26-236973SEC(opens sec.gov)
- 4Gunderson Robert V JR0001193125-25-328741SEC(opens sec.gov)
- 4Gunderson Robert V JR0001179110-21-004698SEC(opens sec.gov)
- 4Gunderson Robert V JR0001179110-20-005297SEC(opens sec.gov)
- 4Gunderson Robert V JR0001179110-19-005455SEC(opens sec.gov)
- 4Gunderson Robert V JR0001179110-18-006189SEC(opens sec.gov)
- 4Theravance Biopharma, Inc.0001179110-17-007539SEC(opens sec.gov)
- 4Vitae Pharmaceuticals, Inc0001104659-16-151947SEC(opens sec.gov)
- 4Vitae Pharmaceuticals, Inc0001104659-16-124076SEC(opens sec.gov)
- 4Theravance Biopharma, Inc.0001179110-16-023945SEC(opens sec.gov)
Companies
Address
C/O ANDERSEN GROUP INC. 333 BUSH STREET, SUITE 1700
SAN FRANCISCO, CA, 94104